Carregant...
Novel peptide isomer strategy for stable inhibition of catecholamine release: Application to hypertension
Although hypertension remains the most potent and widespread cardiovascular risk factor, its pharmacological treatment has achieved only limited success. The chromogranin A derived fragment catestatin inhibits catecholamine release by acting as an endogenous nicotinic cholinergic antagonist, and can...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3523723/ https://ncbi.nlm.nih.gov/pubmed/23129699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.112.202127 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|